Baylor College of Medicine

Reverse Phase Protein Array Protocols & Workflow

Cell or tissue lysates are arrayed on nitrocellulose-coated slides (Grace Bio-labs, Bend, OR) in triplicate using the Aushon 2470 Arrayer (Aushon BioSystems, Billerica, MA) (technical replicates).
ascopubs.org

Classification of molecular subtypes of triple-negative breast cancer using reverse phase protein arrays (RPPAs).

Evaluation of BRCA1/2 mutation status among women with triple-negative breast cancer. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract does not include a full text ...
Baylor College of Medicine

CPRIT Cancer Proteomics and Metabolomics

The Cancer Prevention and Research Institute of Texas is supporting a Cancer Proteomic and Metabolomic Core Facility that provides consultation, instrumentation, technical support and data analysis ...
Seeking Alpha

Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute’s Molecular Tumor Board

Golden, Colorado, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Theralink Technologies (THER), Inc. (OTC: THER) (“Theralink”), a precision oncology company with its exclusive commercial RPPA (reverse phase ...
Business Wire

Dana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics’ RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health innovations, today announced that its ...
WKRG

VIPC Awards Commonwealth Commercialization Fund Grant to GMU for Reverse Phase Protein Array Software Development

RICHMOND, VIRGINIA, UNITED STATES, August 3, 2023/EINPresswire.com/ -- The Virginia Innovation Partnership Corporation (VIPC) today announced that George Mason ...
Fairfax Times

GMU scientists discover cancer resistance signatures using new technology

Scientists at George Mason University’s Center for Applied Proteomics and Molecular Medicine (CAPMM) developed a new technology for testing breast cancer tumors. They used it to discover “novel ...